Wide-Spread Clinical Evidence using the MolecuLightWound ImagingPlatform Demonstrates its Significant Global Adoption and Proven Utility in Wound Care
Toronto, CANADA and Sydney, AUSTRALIA – (September 13, 2022) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announces that its MolecuLight wound imaging platform is featured in 8 presentations and posters at Wounds Australia 2022. The national conference is being hosted from September 14 – 17, 2022 in Sydney, Australia.
“Wounds Australia 2022 brings together leading clinicians, researchers and industry to share best practices in wound care to improve wound care practices and patient outcomes”, says Terry Swanson, NP, Vice Chair of the International Wound Infection Institute, Co-Chair of Wounds Australia 2022 conference andinternational expert in wound management and wound infection. “This includes showcasing new imaging technologies for helping to improve the cleaning and debridement of wounds, such as the MolecuLight novel point-of-care imaging devices, which highlight the presence and location of elevated bacterial burden in wounds. These diagnostic technologies are becoming key tools in informing wound care decision-making at the point-of-care and we are we’re thrilled to have their clinical results shared at multiple talks and posters this coming week”.
The clinical posters and presentation featuring the MolecuLight i:X from Wounds Australia 2022 are as follows:
(b) Clinical Presentations include:
In additional to the clinical posters and presentations at Wounds Australia 2022, the MolecuLight i:X® and DX™ imaging devices will be available for demonstration in the MolecuLight booth #2 in the Exhibit Hall at the International Convention Centre(ICC) in Sydney, Australia.
The MolecuLight i:X® and DX™ are the only imaging devices for the real-time detection of elevated bacterial burden in wounds that are FDA cleared and CE and Health Canada Approved. With unmatched clinical evidence including over 60 peer-reviewed publications and 1,500 patients, they are used by leading wound care facilities globally.